vs

Side-by-side financial comparison of ARGENX SE (ARGX) and RXO, Inc. (RXO). Click either name above to swap in a different company.

ARGENX SE is the larger business by last-quarter revenue ($2.5B vs $1.5B, roughly 1.7× RXO, Inc.). ARGENX SE runs the higher net margin — 35.5% vs -3.1%, a 38.6% gap on every dollar of revenue. On growth, ARGENX SE posted the faster year-over-year revenue change (83.2% vs -11.9%). ARGENX SE produced more free cash flow last quarter ($322.4M vs $-9.0M).

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

RXO, Inc. is a leading transportation and logistics solutions provider headquartered in the United States. Its core service portfolio includes freight brokerage, last-mile delivery for heavy and bulky goods, managed transportation services, and end-to-end supply chain optimization support, primarily catering to clients across the North American manufacturing, retail, and e-commerce segments.

ARGX vs RXO — Head-to-Head

Bigger by revenue
ARGX
ARGX
1.7× larger
ARGX
$2.5B
$1.5B
RXO
Growing faster (revenue YoY)
ARGX
ARGX
+95.1% gap
ARGX
83.2%
-11.9%
RXO
Higher net margin
ARGX
ARGX
38.6% more per $
ARGX
35.5%
-3.1%
RXO
More free cash flow
ARGX
ARGX
$331.4M more FCF
ARGX
$322.4M
$-9.0M
RXO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARGX
ARGX
RXO
RXO
Revenue
$2.5B
$1.5B
Net Profit
$877.2M
$-46.0M
Gross Margin
89.5%
Operating Margin
28.9%
-2.9%
Net Margin
35.5%
-3.1%
Revenue YoY
83.2%
-11.9%
Net Profit YoY
1.3%
-84.0%
EPS (diluted)
$13.25
$-0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARGX
ARGX
RXO
RXO
Q4 25
$2.5B
$1.5B
Q3 25
$1.4B
Q2 25
$1.8B
$1.4B
Q1 25
$1.4B
Q4 24
$1.4B
$1.7B
Q3 24
$1.0B
Q2 24
$901.9M
$930.0M
Q1 24
$913.0M
Net Profit
ARGX
ARGX
RXO
RXO
Q4 25
$877.2M
$-46.0M
Q3 25
$-14.0M
Q2 25
$414.8M
$-9.0M
Q1 25
$-31.0M
Q4 24
$865.6M
$-25.0M
Q3 24
$-243.0M
Q2 24
$-32.5M
$-7.0M
Q1 24
$-15.0M
Gross Margin
ARGX
ARGX
RXO
RXO
Q4 25
89.5%
Q3 25
Q2 25
89.2%
Q1 25
Q4 24
90.2%
Q3 24
Q2 24
89.4%
Q1 24
Operating Margin
ARGX
ARGX
RXO
RXO
Q4 25
28.9%
-2.9%
Q3 25
-0.5%
Q2 25
19.2%
Q1 25
-2.1%
Q4 24
8.7%
-1.4%
Q3 24
-1.9%
Q2 24
-15.4%
Q1 24
-1.3%
Net Margin
ARGX
ARGX
RXO
RXO
Q4 25
35.5%
-3.1%
Q3 25
-1.0%
Q2 25
23.4%
-0.6%
Q1 25
-2.2%
Q4 24
64.1%
-1.5%
Q3 24
-23.4%
Q2 24
-3.6%
-0.8%
Q1 24
-1.6%
EPS (diluted)
ARGX
ARGX
RXO
RXO
Q4 25
$13.25
$-0.28
Q3 25
$-0.08
Q2 25
$6.32
$-0.05
Q1 25
$-0.18
Q4 24
$13.33
$-0.17
Q3 24
$-1.81
Q2 24
$-0.55
$-0.06
Q1 24
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARGX
ARGX
RXO
RXO
Cash + ST InvestmentsLiquidity on hand
$3.5B
$17.0M
Total DebtLower is stronger
$387.0M
Stockholders' EquityBook value
$7.3B
$1.5B
Total Assets
$8.7B
$3.3B
Debt / EquityLower = less leverage
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARGX
ARGX
RXO
RXO
Q4 25
$3.5B
$17.0M
Q3 25
$25.0M
Q2 25
$2.1B
$18.0M
Q1 25
$16.0M
Q4 24
$1.5B
$35.0M
Q3 24
$55.0M
Q2 24
$1.4B
$7.0M
Q1 24
$7.0M
Total Debt
ARGX
ARGX
RXO
RXO
Q4 25
$387.0M
Q3 25
$387.0M
Q2 25
$387.0M
Q1 25
$387.0M
Q4 24
$351.0M
Q3 24
$352.0M
Q2 24
$11.0M
$370.0M
Q1 24
$351.0M
Stockholders' Equity
ARGX
ARGX
RXO
RXO
Q4 25
$7.3B
$1.5B
Q3 25
$1.6B
Q2 25
$6.1B
$1.6B
Q1 25
$1.6B
Q4 24
$5.5B
$1.6B
Q3 24
$1.7B
Q2 24
$4.3B
$579.0M
Q1 24
$582.0M
Total Assets
ARGX
ARGX
RXO
RXO
Q4 25
$8.7B
$3.3B
Q3 25
$3.2B
Q2 25
$7.2B
$3.2B
Q1 25
$3.3B
Q4 24
$6.2B
$3.4B
Q3 24
$3.4B
Q2 24
$4.8B
$1.8B
Q1 24
$1.8B
Debt / Equity
ARGX
ARGX
RXO
RXO
Q4 25
0.25×
Q3 25
0.24×
Q2 25
0.24×
Q1 25
0.24×
Q4 24
0.22×
Q3 24
0.21×
Q2 24
0.00×
0.64×
Q1 24
0.60×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARGX
ARGX
RXO
RXO
Operating Cash FlowLast quarter
$323.3M
$7.0M
Free Cash FlowOCF − Capex
$322.4M
$-9.0M
FCF MarginFCF / Revenue
13.0%
-0.6%
Capex IntensityCapex / Revenue
0.0%
1.1%
Cash ConversionOCF / Net Profit
0.37×
TTM Free Cash FlowTrailing 4 quarters
$594.5M
$-8.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARGX
ARGX
RXO
RXO
Q4 25
$323.3M
$7.0M
Q3 25
$23.0M
Q2 25
$361.8M
$23.0M
Q1 25
$-2.0M
Q4 24
$41.9M
$-7.0M
Q3 24
$-7.0M
Q2 24
$-124.7M
$-5.0M
Q1 24
$7.0M
Free Cash Flow
ARGX
ARGX
RXO
RXO
Q4 25
$322.4M
$-9.0M
Q3 25
$9.0M
Q2 25
$356.6M
$9.0M
Q1 25
$-17.0M
Q4 24
$40.9M
$-19.0M
Q3 24
$-18.0M
Q2 24
$-125.5M
$-16.0M
Q1 24
$-4.0M
FCF Margin
ARGX
ARGX
RXO
RXO
Q4 25
13.0%
-0.6%
Q3 25
0.6%
Q2 25
20.1%
0.6%
Q1 25
-1.2%
Q4 24
3.0%
-1.1%
Q3 24
-1.7%
Q2 24
-13.9%
-1.7%
Q1 24
-0.4%
Capex Intensity
ARGX
ARGX
RXO
RXO
Q4 25
0.0%
1.1%
Q3 25
1.0%
Q2 25
0.3%
1.0%
Q1 25
1.0%
Q4 24
0.1%
0.7%
Q3 24
1.1%
Q2 24
0.1%
1.2%
Q1 24
1.2%
Cash Conversion
ARGX
ARGX
RXO
RXO
Q4 25
0.37×
Q3 25
Q2 25
0.87×
Q1 25
Q4 24
0.05×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARGX
ARGX

Segment breakdown not available.

RXO
RXO

Retail Sector$546.0M37%
Last Mile$298.0M20%
Food And Beverage Sector$225.0M15%
Other Sector$185.0M13%
Managed Transportation$133.0M9%
Automotive Sector$93.0M6%

Related Comparisons